The global diagnostic imaging market is set for steady expansion as healthcare systems worldwide prioritize early, accurate diagnosis and technology-enabled care delivery. According to the report “Diagnostic Imaging Market by Modality, Application, and End User – Global Forecast to 2030,” the market is projected to grow from USD 26.51 billion in 2025 to USD 32.90 billion by 2030, registering a CAGR of 4.4% during the forecast period.
This growth reflects a convergence of clinical need and technological progress. What is fueling demand today? The rising global incidence of chronic diseases—including diabetes, cardiovascular disorders, cancer, and respiratory conditions—continues to drive utilization of advanced diagnostic tools. At the same time, leading manufacturers are introducing next-generation imaging systems that integrate artificial intelligence (AI), telemedicine capabilities, and personalized diagnostic workflows, enabling improved patient outcomes and more efficient healthcare delivery.
Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=411
Innovation and Disease Prevalence Reshape Imaging Strategies
The diagnostic imaging market is evolving as providers seek solutions that deliver higher diagnostic accuracy, faster turnaround times, and better patient experiences. Why does this matter now? Healthcare systems are under pressure to manage growing patient volumes while controlling costs and improving quality of care. Advanced imaging modalities—particularly MRI, ultrasound, CT, and nuclear imaging—are increasingly central to clinical decision-making across neurology, oncology, cardiology, and women’s health.
The report highlights that these innovations are not incremental but transformative, positioning diagnostic imaging as a strategic pillar of value-based healthcare models.
MRI Systems Emerge as a Key Growth Engine
Based on product segmentation, the global diagnostic imaging market includes CT scanners, X-ray imaging systems, ultrasound systems, MRI systems, nuclear imaging systems, and mammography systems. Among these, the MRI systems segment is expected to register the highest growth rate through 2030.
What is driving MRI adoption? The increasing prevalence of neurological, musculoskeletal, and oncological disorders is boosting demand for high-resolution imaging. Technological advancements—such as AI-enhanced image reconstruction, higher-field strength MRI systems (3T and 7T+), and faster scan times—are significantly improving diagnostic confidence and workflow efficiency, making MRI a preferred modality for complex cases.
Ultrasound Adoption Strengthened by Versatility and Affordability
Within ultrasound systems, the radiology/general imaging application segment accounted for the largest market share in 2024 and is also expected to post the highest CAGR during the forecast period. Ultrasound remains widely used for both routine and specialized imaging due to its non-invasive nature, cost-effectiveness, and broad diagnostic utility.
Advancements such as 3D/4D imaging, Doppler, contrast-enhanced ultrasound, and portable point-of-care devices are expanding use cases across clinical settings, reinforcing ultrasound’s role as a frontline diagnostic modality globally.
Hospitals Lead End-User Adoption
By end user, the diagnostic imaging market is segmented into hospitals, diagnostic imaging centers, and other end users. In 2024, hospitals accounted for the largest share of the market.
Who is driving utilization? Hospitals remain the primary adopters of advanced imaging technologies due to their high patient volumes, integrated care models, and access to skilled radiology professionals. Their ability to invest in and upgrade sophisticated imaging infrastructure—supported by reimbursement mechanisms and funding access—positions hospitals at the center of imaging-driven diagnostics.
Asia Pacific Set to Be the Fastest-Growing Region
Where is growth accelerating most rapidly? The Asia Pacific region is expected to register the highest growth rate in the diagnostic imaging market from 2025 to 2030. Key drivers include a large and aging population, increasing prevalence of chronic diseases, growing demand for early and accurate diagnosis, and expanding healthcare infrastructure.
Global imaging leaders are strengthening their manufacturing and commercialization presence in Asia Pacific, supported by favorable government initiatives and improving access to healthcare services in emerging economies.
Competitive Landscape Anchored by Global Leaders
As of 2024, the diagnostic imaging market is led by major multinational players, including Siemens Healthineers (Germany), GE HealthCare (US), Koninklijke Philips N.V. (Netherlands), and FUJIFILM Corporation (Japan). These companies continue to invest heavily in R&D, AI integration, and sustainable imaging technologies to maintain competitive differentiation.
Request for Sample Pages:- https://www.marketsandmarkets.com/requestsampleNew.asp?id=411
Recent Developments Highlight Rapid Technological Progress
May 2025: NVIDIA and Philips collaborated to develop a foundational AI model for MRI, aimed at improving diagnostic accuracy, accelerating scan times, and enhancing image quality across clinical applications.
February 2025: GE HealthCare introduced Freelium, a next-generation MRI platform that operates without helium, offering a more sustainable imaging solution.
January 2025: Siemens Healthineers entered a technology licensing agreement with Kromek Group to produce cadmium zinc telluride (CZT) materials in-house for next-generation multi-modal SPECT systems.
January 2025: Philips launched the Flash Ultrasound System 5100 POC, a portable, high-clarity ultrasound designed for point-of-care use in emergency and critical care settings.
December 2024: Siemens Healthineers received FDA clearance for Magnetom Terra.X, a 7T MRI system featuring first-in-category eight-channel parallel transmission.
Why This Market Matters Now
As healthcare systems worldwide shift toward early diagnosis, precision medicine, and AI-enabled care, diagnostic imaging is becoming a strategic investment priority for providers, policymakers, and technology leaders. For C-suite executives and decision-makers, the market’s steady growth, rapid innovation cycle, and expanding regional opportunities underscore the importance of aligning imaging strategies with long-term clinical and operational goals.
Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/diagnostic-imaging-market-411.html